Five students from the West Valley graduated July 24 from the 2015 Helios Scholars summer internship program at the Translational Genomics Research Institute, or TGen, in Phoenix. Helios Scholars at ...

--Ocular Therapeutix, Inc., an integrated biopharmaceutical company committed to redefining the retina experience, today announced that the first patient has been randomized in the HELIOS-3 Phase 3 ...

A program offered by Helios Care has reduced the need of palliative care patients to visit the emergency room or be admitted to a hospital by 70%, according to the organization. Helios Care ...

First patient randomized into HELIOS-3, which along with HELIOS-2 form the basis of AXPAXLI's registrational program in non-proliferative diabetic retinopathy (NPDR) HELIOS-2 and HELIOS-3 are global, ...

(MENAFN- GlobeNewsWire - Nasdaq) First patient randomized into HELIOS-3, which along with HELIOS-2 form the basis of AXPAXLI's registrational program in non-proliferative diabetic retinopathy (NPDR) ...